DR. JOHN PAUL WINTERS MD NPI 1366648693

NPI Information

  • NPI: 1366648693
  • Provider Name: DR. JOHN PAUL WINTERS, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 11 ROCK ROW STE 120
    WESTBROOK, ME
    ZIP 04092
  • Phone: (207) 303-3300

Map and Directions

Get Directions

NPI Details

DR. John Paul Winters, MD is a hematology and oncology internal medicine in Westbrook, ME with 20 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. John Paul Winters, MD NPI is 1366648693. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE
Graduation Year:2006

The provider's business location address is:

11 ROCK ROW STE 120
WESTBROOK, ME
ZIP 04092-877
Phone: (207) 303-3300
Fax: (207) 250-2139

The NPI 1366648693 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
  • Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Unclassified drugs (HCPCS:J3490)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Injection, hydrocortisone sodium succinate, up to 100 mg (HCPCS:J1720)
  • Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Phosphate level (HCPCS:84100)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:Q0220)
  • Blood test, clotting time (HCPCS:85610)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Folic acid level, serum (HCPCS:82746)
  • Magnesium level (HCPCS:83735)
  • Uric acid level, blood (HCPCS:84550)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Influenza vaccine split virus, preservative free (HCPCS:90662)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Vitamin d-3 level (HCPCS:82306)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)

The enumeration date for this NPI number is 6/24/2007 and was last updated on 4/28/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology20178NEW HAMPSHIRENo
2207RH0003XInternal MedicineHematology & OncologyMD20794MAINEYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.